Eli Lilly and Company (LLY) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 5.33B | 3.22B | 8.84B | 3.09B | 1.67B | 2.47B | 3.71B | 1.47B | 1.17B | -311.9M | 2.19B | 631.9M |
| Operating CF Margin % | 26.94% | 16.71% | 50.2% | 19.84% | 13.09% | 18.28% | 32.45% | 12.97% | 13.3% | -3.33% | 23.05% | 7.6% |
| Operating CF Growth % | 220.18% | 30.35% | 138.04% | 110.54% | 42.85% | 893.14% | 69.53% | 132.03% | -32.62% | -119.74% | -1.23% | -46.6% |
| Net Income | 7.4B | 6.64B | 5.58B | 5.66B | 2.76B | 4.41B | 970.3M | 2.97B | 2.24B | 2.19B | -57.4M | 1.76B |
| Depreciation & Amortization | 509M | 585.7M | 470M | 478.5M | 462.8M | 484.8M | 466.8M | 414.4M | 400.6M | 387.7M | 411M | 366.3M |
| Stock-Based Compensation | 161M | 136.1M | 151.1M | 185.1M | 153.7M | 141.9M | 133.2M | 211.1M | 159.4M | 120.2M | 215.6M | 161.5M |
| Deferred Taxes | -1.48B | -748.1M | 501.4M | -1.07B | -391.6M | -966.7M | -429.8M | -1.01B | -279M | -506.2M | -844.3M | -431.1M |
| Other Non-Cash Items | 409M | 287.3M | 922.7M | 94.4M | 2.05B | 628.9M | 2.58B | 280.4M | 393.3M | 669M | 1.67B | -387.8M |
| Working Capital Changes | -1.66B | -3.67B | 1.21B | -2.26B | -3.36B | -2.22B | -9.8M | -1.4B | -1.75B | -3.17B | 793.3M | -840.2M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -3.92B | -2.8B | -2.98B | -1.83B | -3.35B | -1.92B | -4B | -2.2B | -1.18B | -2.92B | -3.08B | -459.1M |
| Capital Expenditures | -2.33B | -2.55B | -2.09B | -1.7B | -1.51B | -1.5B | -1.17B | -1.4B | -986.3M | -1.07B | -970.3M | -738.2M |
| CapEx % of Revenue | 11.75% | 13.2% | 11.86% | 10.91% | 11.86% | 11.05% | 10.25% | 12.41% | 11.25% | 11.45% | 10.22% | 8.88% |
| Acquisitions | -1.06B | -111.6M | -549.4M | 0 | 0 | 0 | 0 | -947.7M | 0 | -1.62B | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -235M | -148.9M | -751.5M | -170.9M | -1.72B | -339.6M | -2.64B | 95.6M | -161.7M | -22.8M | -2.09B | 358.7M |
| Cash from Financing | -3.47B | -2.88B | 531M | -1.24B | 1.38B | -225.4M | 211.3M | 1.56B | -311.3M | 3.54B | 572M | -1.03B |
| Debt Issued (Net) | 1.02B | -500K | 2.61B | 824.7M | 4.61B | 3.04B | 1.88B | 2.74B | 1.25B | 4.59B | 1.59B | 0 |
| Equity Issued (Net) | -2.36B | -1.51B | -708.1M | -692.2M | -1.2B | -2.05B | -446.1M | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | -1.55B | -1.35B | -1.35B | -1.35B | -1.35B | -1.17B | -1.17B | -1.17B | -1.17B | -1.02B | -1.02B | -1.02B |
| Share Repurchases | -2.36B | -1.51B | -708.1M | -692.2M | -1.2B | -2.05B | -446.1M | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -591M | -25.1M | -30.2M | -30.4M | -686.3M | -45.5M | -47.3M | -8M | -389.8M | -31.6M | -6.8M | -15.6M |
| Net Change in Cash | -1.99B | -2.52B | 6.42B | 282.6M | -175.1M | -100.6M | 145.4M | 763.4M | -358.4M | 437.8M | -313.7M | -851.4M |
| Free Cash Flow | 3.01B | 677.9M | 8.61B | 1.28B | -1.6B | 726.6M | -458.9M | 63.4M | 179.7M | -1.96B | -1.81B | -204.4M |
| FCF Margin % | 15.19% | 3.51% | 48.93% | 8.25% | -12.58% | 5.37% | -4.01% | 0.56% | 2.05% | -20.99% | -19.07% | -2.46% |
| FCF Growth % | 287.83% | -6.7% | 1976.66% | 1923.66% | -990.87% | 137.01% | 74.67% | 131.02% | -78.27% | -291.68% | -215.79% | -155.29% |
| FCF per Share | 3.36 | 0.75 | 9.58 | 1.43 | -1.78 | 0.80 | -0.51 | 0.07 | 0.20 | -2.17 | -1.91 | -0.22 |
| FCF Conversion (FCF/Net Income) | 0.72x | 0.49x | 1.58x | 0.55x | 0.60x | 0.56x | 3.83x | 0.49x | 0.52x | -0.14x | -38.14x | 0.36x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |